As shown in Fig. 5, the high expressions of the CBX family (including CBX2, CBX3, CBX5, and CBX6) in tumor tissues were related to the worse OS of DLBCL patients, whereas high expression of CBX1 was correlated with better prognosis of patients. This evidence concerns the gene CBX2 and diffuse large B-cell lymphoma.